Bettina Klug, PEI: The Future of Genetic Modification in Vaccine Development

The vaccine industry is in a time where there is a lot to be excited about around new developments. However, these new approaches to vaccine development bring significant challenges in terms of bringing them to market. Earlier this year the VaccineNation team were able to sit down with Dr Bettina Klug, Scientific Administrator at the Paul-Ehrlich-Institut to understand her thought …